We generate breakthrough discoveries that advance scientific understanding and lead to new interventions for preventing and treating bipolar disorder. BD2 is part of the CNS Quest, an initiative to accelerate discoveries, advance treatments and care, and improve the daily lives of people impacted by Parkinson’s disease, autism, bipolar disorder, and other CNS conditions—shortening the distance from lab to living well. The CNS Quest is a program of the Sergey Brin Family Foundation and Cataly